Literature DB >> 8912399

Excitotoxic lesions of the basolateral amygdala impair the acquisition of cocaine-seeking behaviour under a second-order schedule of reinforcement.

R B Whitelaw1, A Markou, T W Robbins, B J Everitt.   

Abstract

In these experiments we sought to establish the intravenous (i.v.) self-administration of cocaine under a second-order schedule of reinforcement in order: (i) to obtain reliable, drug-free levels of responding with cocaine as a reinforcer, and (ii) to enable investigation of the neural mechanisms by which arbitrary cues gain motivational salience and, as conditioned reinforcers, control over drug-seeking behaviour. Initially, each infusion of cocaine was made contingent upon a response on one of two identical levers and was paired with a 20-s light conditioned stimulus (CS). Responses on the second lever were recorded, but had no programmed consequence. When rats acquired stable rates of self-administration, a second-order schedule of the type FRx(FRy:S) was introduced, with values of "x" being increased progressively to 10 and then "y" from 2 through 8. Priming (i.e. non-contingent) infusions of cocaine were never given. Once the first infusion was obtained under the second-order schedule, further infusions were made contingent on each response (to a maximum of ten infusions/day). Each stage was repeated daily until the first infusion of each session was achieved within a 5-min criterion. Rats with bilateral, excitotoxic lesions of the basolateral amygdala readily acquired the i.v. self-administration of cocaine under a continuous reinforcement schedule, initially administering more infusions and maintaining a slightly elevated level of self-administration than controls. Despite increased numbers of CS/drug pairings, basolateral amygdala-lesioned rats were severely impaired in the acquisition of the second-order schedule of i.v. cocaine reinforcement. Lesioned rats showed a cocaine dose-response function that was shifted upwards relative to control subjects. There was no significant difference between drug-naive amygdala-lesioned and control animals in the locomotor response to intraperitoneal injections of cocaine. These experiments indicate the feasibility and utility of second-order schedules in studying the neurobehavioural basis of cocaine-seeking behaviour. They suggest a dissociation in the neural mechanisms underlying cocaine-taking and cocaine seeking behaviour, and demonstrate the potential importance of the basolateral amygdala in the processes by which previously neutral stimuli gain control over drug-seeking behaviour.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8912399

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  41 in total

1.  A comparison of responding maintained under second-order schedules of intramuscular cocaine injection or food presentation in squirrel monkeys.

Authors:  J L Katz
Journal:  J Exp Anal Behav       Date:  1979-11       Impact factor: 2.468

2.  6-Hydroxydopamine lesions of the nucleus accumbens, but not of the caudate nucleus, attenuate enhanced responding with reward-related stimuli produced by intra-accumbens d-amphetamine.

Authors:  J R Taylor; T W Robbins
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

3.  Lesions of the basolateral amygdala abolish the ability of drug associated cues to reinstate responding during withdrawal from self-administered cocaine.

Authors:  W M Meil; R E See
Journal:  Behav Brain Res       Date:  1997-09       Impact factor: 3.332

4.  Cocaine-reinforced behavior in rats: effects of reinforcement magnitude and fixed-ratio size.

Authors:  R Pickens; T Thompson
Journal:  J Pharmacol Exp Ther       Date:  1968-05       Impact factor: 4.030

5.  Fluctuations in nucleus accumbens dopamine concentration during intravenous cocaine self-administration in rats.

Authors:  R A Wise; P Newton; K Leeb; B Burnette; D Pocock; J B Justice
Journal:  Psychopharmacology (Berl)       Date:  1995-07       Impact factor: 4.530

6.  Differential effects of excitotoxic lesions of the basolateral amygdala, ventral subiculum and medial prefrontal cortex on responding with conditioned reinforcement and locomotor activity potentiated by intra-accumbens infusions of D-amphetamine.

Authors:  L H Burns; T W Robbins; B J Everitt
Journal:  Behav Brain Res       Date:  1993-06-30       Impact factor: 3.332

7.  Isolation rearing enhances the locomotor response to cocaine and a novel environment, but impairs the intravenous self-administration of cocaine.

Authors:  G D Phillips; S R Howes; R B Whitelaw; L S Wilkinson; T W Robbins; B J Everitt
Journal:  Psychopharmacology (Berl)       Date:  1994-07       Impact factor: 4.530

8.  Defeat engenders pentylenetetrazole-appropriate responding in rats: antagonism by midazolam.

Authors:  J A Vivian; E M Weerts; K A Miczek
Journal:  Psychopharmacology (Berl)       Date:  1994-12       Impact factor: 4.530

9.  Amygdala dopamine levels are markedly elevated after self- but not passive-administration of cocaine.

Authors:  J M Wilson; J N Nobrega; W A Corrigall; K M Coen; K Shannak; S J Kish
Journal:  Brain Res       Date:  1994-12-30       Impact factor: 3.252

Review 10.  Limbic-striatal interactions in reward-related processes.

Authors:  T W Robbins; M Cador; J R Taylor; B J Everitt
Journal:  Neurosci Biobehav Rev       Date:  1989 Summer-Fall       Impact factor: 8.989

View more
  94 in total

1.  Brain-derived neurotrophic factor controls dopamine D3 receptor expression: implications for neurodevelopmental psychiatric disorders.

Authors:  Pierre Sokoloff; Olivier Guillin; Jorge Diaz; Patrick Carroll; Nathalie Griffon
Journal:  Neurotox Res       Date:  2002 Nov-Dec       Impact factor: 3.911

2.  What and when to "want"? Amygdala-based focusing of incentive salience upon sugar and sex.

Authors:  Stephen V Mahler; Kent C Berridge
Journal:  Psychopharmacology (Berl)       Date:  2011-12-14       Impact factor: 4.530

Review 3.  Brain circuitry and the reinstatement of cocaine-seeking behavior.

Authors:  Peter W Kalivas; Krista McFarland
Journal:  Psychopharmacology (Berl)       Date:  2003-03-22       Impact factor: 4.530

4.  Basolateral amygdala neurons encode cocaine self-administration and cocaine-associated cues.

Authors:  Regina M Carelli; Jefferson G Williams; Jonathan A Hollander
Journal:  J Neurosci       Date:  2003-09-10       Impact factor: 6.167

5.  Neural substrates of olfactory discrimination learning with auditory secondary reinforcement. I. Contributions of the basolateral amygdaloid complex and orbitofrontal cortex.

Authors:  Graham A Cousens; Tim Otto
Journal:  Integr Physiol Behav Sci       Date:  2003 Oct-Dec

6.  Changes in expression of c-Fos protein following cocaine-cue extinction learning.

Authors:  B Á Nic Dhonnchadha; B F Lovascio; N Shrestha; A Lin; K A Leite-Morris; H Y Man; G B Kaplan; K M Kantak
Journal:  Behav Brain Res       Date:  2012-06-18       Impact factor: 3.332

7.  Inactivation of the central nucleus of the amygdala reduces the effect of punishment on cocaine self-administration in rats.

Authors:  YueQiang Xue; Jeffery D Steketee; WenLin Sun
Journal:  Eur J Neurosci       Date:  2012-02-06       Impact factor: 3.386

Review 8.  The ventral pallidum: Subregion-specific functional anatomy and roles in motivated behaviors.

Authors:  David H Root; Roberto I Melendez; Laszlo Zaborszky; T Celeste Napier
Journal:  Prog Neurobiol       Date:  2015-04-06       Impact factor: 11.685

9.  Microinjection of the delta-opioid receptor selective antagonist naltrindole 5'-isothiocyanate site specifically affects cocaine self-administration in rats responding under a progressive ratio schedule of reinforcement.

Authors:  Sara Jane Ward; David C S Roberts
Journal:  Behav Brain Res       Date:  2007-05-18       Impact factor: 3.332

10.  Second-order stimuli do not always increase overall response rates in second-order schedules of reinforcement in the rat.

Authors:  David I G Wilson; E M Bowman
Journal:  Psychopharmacology (Berl)       Date:  2004-04-09       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.